Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Targets Trust XXIV TARGETS 7%INTC
TOI | US
4.74
USD0.51
12.06%
TOI | US
Loading StockChartView...
About Targets Trust XXIV TARGETS 7%INTC
Sector
Healthcare
Industry
Medical Care Facilities
Earnings date
30/06/2024
As of date
04/06/2026
Close
4.74
Open
4.25
High
4.83
Low
4.23
The Oncology Institute Inc. an oncology company provides various medical oncology services in the United States. The company operates in three segments: Dispensary Patient Services and Clinical Trials & Other. It offers physician services in-house infusion and dispensary clinical trial services radiation outpatient blood product transfusions and patient support services. The company also offers and manages clinical trial services such as managing clinical trials palliative care programs and stem cell transplants services. It serves adult and senior cancer patients. The Oncology Institute Inc. was founded in 2007 and is headquartered in Cerritos California.
View LessTOI | US
Risk
66.2
Sharpe
0.52
Luna's Score
55/100
Recommendation
Hold
Luna says (TOI | US)
What's Working
Positive Momentum
Strength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Weak Operating Margin (< 10%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
85.6%1 month
66.2%3 months
73.3%6 months
74.3%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.96
Debt to equity
4.14
Debt to assets
0.67
Ent. to EBITDA
-1.87
Ent. to rev.
0.28
PEG
-
Other Fundamentals
EBITDA
-57.34M
MarketCap
357.82M
MarketCap(USD)
357.82M
Div. yield
-
Op. margin
-16.60
Erngs. growth
-
Rev. growth
22.90
Ret. on equity
-125.59
Short ratio
2.58
Short perc.
0.51
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.78
Range1M
1.19
Range3M
2.33
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.46
Price X volume
12.27M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.87 | 13.85 | Cheaper |
| Ent. to Revenue | 0.28 | 1.73 | Cheaper |
| PE Ratio | - | 22.94 | - |
| Price to Book | 0.96 | 14.91 | Cheaper |
| Dividend Yield | - | 1.25 | - |
| Std. Deviation (3M) | 73.33 | 51.88 | Riskier |
| Debt to Equity | 4.14 | 5.15 | Par |
| Debt to Assets | 0.67 | 0.46 | Expensive |
| Market Cap | 357.82M | 6.67B | Emerging |
